Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06179004 · ClinicalTrials.gov registry record · Phase 3
Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery
A Phase 3 study of Distal Radius Fractures and Wrist Fractures, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06179004 is a Phase 3 study of Distal Radius Fractures and Wrist Fractures that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 171-participant average among 4 other Distal Radius Fractures trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06179004, a Phase 3 study of Distal Radius Fractures and Wrist Fractures, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Orthopedic wrist procedures often cause significant postoperative pain. A supraclavicular nerve block is an effective and proven method to help reduce postoperative pain and decrease opioid use around the time of upper extremity surgery. Liposomal bupivacaine (Exparel) has been approved for use around the brachial plexus, but its analgesic efficacy has limited data. The investigators' goal is to evaluate the effectiveness of Exparel as compared to plain bupivacaine. The investigators hope to ensure the quality of pain control around the time of distal radius fracture repair and reduce the variability of care at the investigators institution by prospectively and rigorously collecting perioperative data during this study.
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
- DRUG Bupivacaine Hydrochloride
Study Locations (1)
North Carolina
- UNC Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2026-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06179004
The ClinicalTrials.gov registry entry for NCT06179004 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 171-participant average among 4 other Distal Radius Fractures trials with a reported enrollment target (42% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Distal Radius Fractures appearing as the primary indexed condition, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT06179004 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06179004 about?
NCT06179004 is a clinical study titled "Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery". Orthopedic wrist procedures often cause significant postoperative pain. A supraclavicular nerve block is an effective and proven method to help reduce postoperative pain and decrease opioid use around the time of upper extremity surgery. Liposomal bupivacaine (Exparel) has been approved for use arou...
What is the current status of trial NCT06179004?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2024-04-10. Estimated completion is 2026-10.
What conditions does trial NCT06179004 study?
This clinical trial studies the following conditions: Distal Radius Fractures, Wrist Fractures.
What interventions are being tested in trial NCT06179004?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Bupivacaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT06179004?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06179004 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Distal Radius Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Is Sensorimotor Training Effective Following a Distal Radius Fracture?
RECRUITING · NA
-
Impact of Early ADL Education on Outcomes Post DRF ORIF
RECRUITING · Phase 1
-
Hematoma Block Versus Bier Block for Closed Fracture Reduction
ACTIVE NOT RECRUITING · Early Phase 1
-
ORIF Distal Radius Blood Flow Restriction Therapy
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.